Pfizer’s Troxyca And The Limits Of Advisory Committee Review For Opioids

FDA approved Pfizer’s oxycodone/naltrexone extended release opioid with abuse deterrent claims similar to Embeda. That isn’t the label FDA’s advisory committee supported.